Benzonitrile

Benzonitrile

SCHEMBL6072015

I.N#Cc1ccccc1.N#Cc1ccccc1.[Pd]

nearest known ligand 0.88

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Benzonitrile. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.88
MAOB P27338 4/20 0.54
MAOA P21397 3/20 0.54
APP P05067 1/20 0.47
ALDH1A1 P00352 3/20 0.46
CYP2A6 P11509 2/20 0.46
CA12 O43570 1/20 0.46
CA2 P00918 1/20 0.46
CA3 P07451 1/20 0.46
CA6 P23280 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46
MAPT P10636 3/20 0.42
HDAC8 Q9BY41 2/20 0.42
ENPP2 Q13822 2/20 0.40
LOXL2 Q9Y4K0 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzonitrile SCHEMBL27692839 0.97
Benzonitrile SCHEMBL4272158 0.97 TSHR (0.93) TSHRMAOBMAOAAPPALDH1A1
Benzonitrile SCHEMBL343530 0.97 TSHR (0.93) TSHRMAOBMAOAAPPALDH1A1
Benzonitrile SCHEMBL2708030 0.97
Benzonitrile SCHEMBL3650085 0.94 TSHR (0.88) TSHRMAOBMAOAAPPALDH1A1
Benzonitrile SCHEMBL3082428 0.94 TSHR (0.88) TSHRMAOBMAOAAPPALDH1A1
Benzonitrile SCHEMBL6071819 0.94 TSHR (0.88) TSHRMAOBMAOAAPPALDH1A1
Benzonitrile SCHEMBL11044747 0.94
Benzonitrile SCHEMBL6640 0.94
Benzonitrile SCHEMBL21752925 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7081544-B2 aromatic fused phosphepine ligands, e.g., 4-Phenyl-4,5-dihydro-3H-dinaphtho[2,1-c; 1',2'-e]phosphepine and their preparation from 2,2'-dimethylbiphenyls or binaphthyls and aminophosphorus dichlorides or aryl or alkyl phosphorus dichlorides; hydrogenation catalysts with metal compounds DEGUSSA AG (DE) 2006-07-25 US disclosed
US-20040249184-A1 Novel chiral ligands, transition metal complexes thereof, and the catalytic use of the same EVONIK DEGUSSA GMBH (DE) 2004-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040249184-A1 Novel chiral ligands, transition metal complexes thereof, and the catalytic use of the same SOD1, COASY, SPR TSHR 3769/4885MAOB 483/4885MAOA 394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.